Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA withdrawing proposals

This article was originally published in The Tan Sheet

Executive Summary

GMPs for homeopathic products, "Food Labeling, Nutrient Content Claims & Health Claims" among draft proposals FDA is considering withdrawing, according to 1April 22 Federal Register notice. Agency plans to withdraw 84 proposed rules that have not been finalized, are not considered public health priorities, and which have not received agency action in more than 10 years. "FDA's actions are part of an overall regulatory reform strategy initiated by" HHS Secretary Tommy Thompson, the notice states. Commissioner Mark McClellan, MD/PhD, says action is consistent with agency's commitment to "transparency in its regulatory actions." FDA has included a 2press release and 3FAQ page on its Web site to clear up uncertainties; comments will be accepted through July 21...

You may also be interested in...

Hanmi And LG Chem Highlight Vaccine Prowess, Novel R&D At JPM

Hanmi showcases at JPM its contract production capabilities for COVID-19 vaccines as South Korea prepares to bring in candidates from several global developers, while LG Chem highlights progress across multiple pipeline projects.

Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori

The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker

Vaccination Health Next Stop For Dentovations’ Self+ Immunity Supplement Line

Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts